M Dirnberger - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Dirnberger

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Scientific Reports|November 3, 2015

NEFI: Network Extraction From ImagesM Dirnberger, T Kehl, A Neumann

Journal of Clinical Gastroenterology|June 1, 1981

Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride)J G Page, G M Dirnberger

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2018

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaW Jurczak, P L Zinzani, G Gaidano, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Scientific Reports|November 3, 2015

NEFI: Network Extraction From ImagesM Dirnberger, T Kehl, A Neumann

Journal of Clinical Gastroenterology|June 1, 1981

Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride)J G Page, G M Dirnberger

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2018

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaW Jurczak, P L Zinzani, G Gaidano, et al.

Pageof 1